AP Biosciences Statistics

Total Valuation

AP Biosciences has a market cap or net worth of TWD 10.74 billion. The enterprise value is 9.70 billion.

Market Cap	10.74B
Enterprise Value	9.70B

Important Dates

The next estimated earnings date is Monday, August 10, 2026.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

AP Biosciences has 85.57 million shares outstanding. The number of shares has increased by 6.40% in one year.

Current Share Class	85.57M
Shares Outstanding	85.57M
Shares Change (YoY)	+6.40%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	5.87%
Owned by Institutions (%)	6.72%
Float	43.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	8.92
P/TBV Ratio	8.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-21.13
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.14

Financial Position

The company has a current ratio of 33.99, with a Debt / Equity ratio of 0.05.

Current Ratio	33.99
Quick Ratio	32.61
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-344.92

Financial Efficiency

Return on equity (ROE) is -34.45% and return on invested capital (ROIC) is -21.65%.

Return on Equity (ROE)	-34.45%
Return on Assets (ROA)	-20.77%
Return on Invested Capital (ROIC)	-21.65%
Return on Capital Employed (ROCE)	-37.58%
Weighted Average Cost of Capital (WACC)	2.61%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +132.78% in the last 52 weeks. The beta is -0.30, so AP Biosciences's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	+132.78%
50-Day Moving Average	181.54
200-Day Moving Average	150.84
Relative Strength Index (RSI)	28.26
Average Volume (20 Days)	652,816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-471.51M
Pretax Income	-459.05M
Net Income	-459.05M
EBITDA	-456.35M
EBIT	-471.51M
Earnings Per Share (EPS)	-5.38

Full Income Statement

Balance Sheet

The company has 1.10 billion in cash and 56.63 million in debt, with a net cash position of 1.04 billion or 12.16 per share.

Cash & Cash Equivalents	1.10B
Total Debt	56.63M
Net Cash	1.04B
Net Cash Per Share	12.16
Equity (Book Value)	1.20B
Book Value Per Share	14.05
Working Capital	1.12B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -362.54 million and capital expenditures -23.30 million, giving a free cash flow of -385.84 million.

Operating Cash Flow	-362.54M
Capital Expenditures	-23.30M
Depreciation & Amortization	15.16M
Net Borrowing	-11.45M
Free Cash Flow	-385.84M
FCF Per Share	-4.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AP Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.40%
Shareholder Yield	-6.40%
Earnings Yield	-4.27%
FCF Yield	-3.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1